Vyacheslav
Owns the product direction, ecosystem architecture and fundraising roadmap.
Team & founder
Founder-led today. Built to scale with specialists.
VYTA’s product direction, ecosystem architecture and fundraising roadmap are founder-owned. The pre-seed round builds the specialist team around a validated product.
Founder-ledclear product ownership
Specialist coreAI, mobile and growth
Partner-readyclinical and compliance depth
V
01Product direction
02Ecosystem architecture
03Fundraising roadmap
Founder mandate
One owner for the product story and the product reality.
At this stage, concentrated ownership keeps the proposition coherent while the product is tested, corrected and prepared for commercial release.
Keep the user promise clear.
Translate the Personal Health Intelligence vision into a daily product people can understand, use and return to.
Build one reusable core.
Connect product decisions to the shared identity, consent, data and intelligence architecture required for expansion.
Raise against proof.
Use the pre-seed round to reach commercial metrics and make the next financing decision evidence-based.
Operating principle
Stay lean where ownership matters. Add specialists where depth, speed and regulated execution matter more.
Build strategy
The round adds the capabilities needed for commercial proof.
The target is a compact specialist team around the existing product—not a large organisation before retention and conversion are proven.
Roles can be filled through direct hires or specialist partners, depending on speed, quality and capital efficiency.
AI / Data
Model orchestration, health intelligence, evaluation and data quality.
Build with roundMobile / Backend
Production reliability, integrations, analytics and release quality.
Build with roundGrowth
Acquisition, subscription packaging, retention and channel experiments.
Build with roundAdvisors
Clinical, compliance and consumer-health expertise for responsible expansion.
Specialist networkOperating model
Build the team in the same order as the evidence.
Each capability is added against a concrete commercial or product milestone, keeping the organisation aligned with the 18-month proof plan.
Now: focus
Founder-led direction, working prototype, infrastructure and early product validation.
After funding: depth
Add AI/data and mobile/backend strength to reach a stable commercial release.
With traction: scale
Expand growth, partnerships and advisory depth against measured retention and conversion.
How we build
Small core. Clear accountability. Specialist depth.
Product before headcount.
Hiring follows real bottlenecks and proof points rather than an abstract organisational chart.
One intelligence core.
New capabilities strengthen the same shared product and data foundation instead of creating isolated teams.
Trust built early.
Clinical and compliance expertise supports expansion before connected-health complexity becomes expensive to unwind.
Build the specialist team around a product that already exists.
The €250K pre-seed round is designed to turn founder-led progress into commercial evidence and seed readiness.